Previous 10 | Next 10 |
HEC agreed to merge with Talkspace in mid-January 2021 and the stock has been flat since the announcement. Slated to close at the end of Q1 or early Q2'21, I believe Talkspace represents an attractive market with strong growth and a reasonable valuation. Some overhang exists due t...
The telehealth industry witnessed an impressive run over the past year, as they were able to capitalize on the increased demand for virtual healthcare services amid the pandemic. While Teladoc (TDOC) and American Well (AMWL) have delivered double-digit gains so far this year, will these compa...
In a sector full of confusing scientific data, seemingly endless clinical trials, and hefty competition, it can be difficult to pick the healthcare stocks that will soar. But there are some trends that investors can follow -- think telehealth services offered by companies like Teladoc Hea...
Share price up 237% YoY, company valuation up 4,700% in 4 years. What is all the excitement about? Is it justified? Is Teladoc a smart investment going forward? What are Teladoc's prospects after their acquisition of Livongo? Where are the threats to Teladoc's business? Sh...
Gainers: Lianluo Smart (LLIT) +101%, Sundial Growers (SNDL) +51%, Monopar Therapeutics (MNPR) +38%, Regional Health Properties (RHE) +20%, Conversion Labs (CVLB) +18%.Losers: Vir Biotechnology (VIR) -31%, Zymeworks ZYME -25%, American Well (AMWL) -...
Employee wellness programs have become a top priority for companies all over the world. Such programs have been shown to help improve mental, financial, and physical health. In fact, a report from the Harvard Business School once found that for American-based wellness companies, medical...
Insider sold 5% of the company at $27.50 via a secondary offering. The vaccine rollout should make for tough telehealth visit comps this year. The stock will struggle this year on limited growth and valuation concerns at nearly 30x '21 sales targets. For further details see:...
Telehealth faces barriers to growth that many bulls fail to acknowledge, which could hurt Amwell given its lack of focus on cost control. Amwell's liquidity position is very strong and should be able to handle cash burn or pursue some large, value-adding acquisitions in the near futur...
Amwell (AMWL) has priced its public offering of ~11.3M Class A shares offered by certain stockholders at $27.50/share.Underwriters' over-allotment is an additional ~1.7M shares.Amwell will not receive any proceeds from this offering. Closing date is January 20.Previously (Jan. 12): Amwell sto...
Amwell® (NYSE: AMWL), a national telehealth leader, today announced the pricing of a public offering of 11,280,647 shares of its Class A common stock by certain stockholders (the “Selling Stockholders”) at a public offering price of $27.50 per share. In addition, the ...
News, Short Squeeze, Breakout and More Instantly...
American Well Corporation Class A Company Name:
AMWL Stock Symbol:
NYSE Market:
American Well Corporation Class A Website:
2024-07-27 19:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Boston, July 17, 2024 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leader in hybrid care enablement, will report its second quarter 2024 operating results on Wednesday, July 31. Following the distribution of the earnings release via wire services, the Amwell management t...